Press Release Archive
-
CELLSEARCH® System Recognized as Landmark Innovation in Cancer ResearchSeminal Study included in list of Most Significant Publications of past 20 years in Clinical Cancer Research.
-
Janssen Submits Supplemental New Drug Application to U.S. FDA for All-Oral, Once-Daily OLYSIO® (Simeprevir) in Combination with SofosbuvirFiling Supported by Data from the Phase 3 OPTIMIST-1 and -2 Clinical Trials Evaluating OLYSIO® Combination Therapy in Hepatitis C Patients with and without Cirrhosis
-
Johnson & Johnson Health and Wellness Solutions Announces New Mobile Health Assessment
-
Phase 2B Findings Published In The New England Journal Of Medicine Demonstrate Significant Efficacy Of Guselkumab In Treatment Of Moderate To Severe Plaque PsoriasisGuselkumab, an anti-interleukin-23 monoclonal antibody, showed improvements in primary and secondary endpoints compared with placebo and active comparator adalimumab, an anti-tumor necrosis ...
-
CELLSEARCH® System chosen as platform for new research on PD-L1 and Circulating Tumor CellsStudy demonstrates feasibility of liquid biopsy for use in breast cancer trials
-
Daratumumab Expanded Access Program Open to Eligible U.S. Patients with Heavily Pre-Treated Multiple MyelomaJanssen, with support from the Multiple Myeloma Research Foundation, opens EAP to help patients in immediate need of new treatment options
-
Investigational HIV Vaccine Regimen Shows Encouraging Results in Non-Human PrimatesPre-Clinical Data Published in Science Forms Basis for Early Human Clinical Trials
-
STELARA® Receives European Commission Approval For Treatment Of Adolescents With Moderate-To-Severe Psoriasis In EuropeApproval provides new therapeutic option for plaque psoriasis patients aged 12 and older for whom limited approved treatment options are available
-
SIMPONI® Receives European Commission Approval For Treatment Of Non-Radiographic Axial SpondyloarthritisApproval Marks Fifth Indication for SIMPONI in Europe
-
Johnson & Johnson Consumer Companies, Inc. Collaborates with Walgreens to Improve Health Outcomes